{"id":6186,"date":"2025-08-19T23:02:53","date_gmt":"2025-08-19T23:02:53","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/08\/19\/biotech-news-regenxbio-medicare-viking-cms\/"},"modified":"2025-08-19T23:02:53","modified_gmt":"2025-08-19T23:02:53","slug":"biotech-news-regenxbio-medicare-viking-cms","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/08\/19\/biotech-news-regenxbio-medicare-viking-cms\/","title":{"rendered":"STAT+: FDA delays decision on Regenxbio gene therapy"},"content":{"rendered":"<p>    STAT+: FDA delays decision on Regenxbio gene therapy<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Good morning. Today we look at what some people in the industry are calling a \u201cpharm to table\u201d trend. Read on to learn more about it.<\/p>\n<h2 class=\"wp-block-heading\" id=\"h-viking-oral-obesity-pill-study-results-disappoint\">Viking oral obesity pill study results disappoint<\/h2>\n<p><em>From my colleague Allison DeAngelis<\/em>: A new oral weight loss drug developed by Viking Therapeutics hit the mark in a mid-stage clinical trial, but the side effect and discontinuation rates have disappointed investors.\u00a0<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/08\/19\/biotech-news-regenxbio-medicare-viking-cms\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/08\/19\/biotech-news-regenxbio-medicare-viking-cms\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: FDA delays decision on Regenxbio gene therapy Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. Today we look at what some people in the industry are calling a \u201cpharm to table\u201d trend. Read on to learn more about it. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-6186","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6186"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=6186"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6186\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=6186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=6186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=6186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}